Enzychem Lifesciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,841	10,304	15,470	7,683	2,784
Short-Term Investments	84,979	106,771	121,604	185,173	91,803
Trading Asset Securities	-	-	276	-	-
Cash & Short-Term Investments	92,821	117,075	137,350	192,856	94,587
Cash Growth	-20.72%	-14.76%	-28.78%	103.89%	4.51%
Accounts Receivable	3,933	8,022	11,625	6,358	5,206
Other Receivables	295.59	513.16	1,425	3,428	661.09
Receivables	9,405	17,643	20,207	10,312	5,986
Inventory	11,879	12,113	14,946	9,794	8,355
Prepaid Expenses	300.92	78.09	134.77	73.65	169.68
Other Current Assets	1,369	1,321	1,837	7,277	685.8
Total Current Assets	115,774	148,230	174,475	220,313	109,783
Property, Plant & Equipment	19,149	24,160	26,164	23,294	15,431
Long-Term Investments	977.73	975.89	1,574	476.43	486.51
Goodwill	1,521	1,480	1,480	-	-
Other Intangible Assets	2,291	3,724	4,371	2,186	6,469
Long-Term Deferred Tax Assets	29.88	612.97	571.39	-	-
Long-Term Deferred Charges	64.81	-	-	0	-
Other Long-Term Assets	2,005	2,536	2,859	1,233	884.1
Total Assets	148,592	181,744	211,546	247,555	133,084
Accounts Payable	1,348	2,514	6,493	1,496	2,250
Accrued Expenses	5.76	7.97	10.21	59.78	16.12
Short-Term Debt	3,000	3,410	2,280	33,750	45,629
Current Portion of Long-Term Debt	237.31	425	1,113	2,492	2,867
Current Portion of Leases	513.86	699.55	654.19	344.64	126.7
Current Income Taxes Payable	25.58	18.5	-	-	-
Other Current Liabilities	3,102	4,299	3,603	4,142	2,732
Total Current Liabilities	8,232	11,375	14,154	42,284	53,621
Long-Term Debt	914.14	-	1,025	683.32	3,175
Long-Term Leases	173.54	345	584.45	509.09	179.98
Pension & Post-Retirement Benefits	433.11	1,079	440.23	2,334	627.21
Long-Term Deferred Tax Liabilities	-	668.21	715.09	-	819.58
Other Long-Term Liabilities	72.3	6,795	0	0	0
Total Liabilities	9,825	20,261	16,919	45,811	58,422
Common Stock	42,533	42,533	42,533	42,144	4,166
Additional Paid-In Capital	108,957	108,957	108,431	309,804	194,149
Retained Earnings	1,876	19,530	41,910	-151,053	-124,665
Treasury Stock	-15,976	-10,822	-	-	-
Comprehensive Income & Other	150.44	155.98	641.6	580.01	822.79
Total Common Equity	137,540	160,353	193,516	201,474	74,472
Minority Interest	1,227	1,130	1,111	-	-
Shareholders' Equity	138,767	161,483	194,627	201,744	74,662
Total Liabilities & Equity	148,592	181,744	211,546	247,555	133,084
Total Debt	4,839	4,880	5,657	37,779	51,977
Net Cash (Debt)	87,982	112,195	131,693	155,077	42,609
Net Cash Growth	-21.58%	-14.81%	-15.08%	263.95%	-10.18%
Net Cash Per Share	1135.47	1370.30	1550.62	1967.48	843.86
Filing Date Shares Outstanding	76.39	79.62	85.07	84.29	49.99
Total Common Shares Outstanding	76.39	79.62	85.07	84.29	49.99
Working Capital	107,542	136,855	160,321	178,028	56,163
Book Value Per Share	1800.43	2014.00	2274.90	2390.31	1489.80
Tangible Book Value	133,728	155,150	187,665	199,289	68,003
Tangible Book Value Per Share	1750.52	1948.64	2206.12	2364.38	1360.38
Land	8,249	8,249	8,090	6,249	6,249
Buildings	8,495	9,855	9,883	9,055	6,092
Machinery	20,206	21,579	21,252	18,549	14,238
Construction In Progress	-	89	122.75	68.5	194.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.